Orphan Drugs

Czech version

Authors: J. Kolář; M. Chalabala; H. Šrámková
Authors‘ workplace: Ústav aplikované farmacie Farmaceutické fakulty Veterinární a farmaceutické univerzity, Brno 1 Katedra galenickej farmácie Farmaceutickej fakulty Univerzity Komenského, Bratislava
Published in: Čes. slov. Farm., 2001; , 59-65
Category:

Overview

Orphan DrugsThe paper discusses the problems of orphan drugs from the standpoint of the attitude of stateauthorities in the USA, Japan, and particularly Europe (the European Union) to their definitionand the formation of appropriate legislation – financial provision for the development, production,provision of exclusive sale rights – which warranties the availability of the drug to every patientsuffering from a rare disease.

Key words:
orphan drugs – definition – legislation – USA – Europe

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.

Labels

Pharmacy Clinical pharmacology

BERGENIA CRASSIFOLIA BERGENIA CRASSIFOLIA (L.) FRITSCHIN VITRO IN VITRO

Article was published in

Czech and Slovak Pharmacy

2001 Issue 2